67
Views
90
CrossRef citations to date
0
Altmetric
Original Article

Plasma YKL-40: A New Potential Marker of Fibrosis in Patients with Alcoholic Cirrhosis?

, , , , , & show all
Pages 582-590 | Received 16 Oct 1996, Accepted 10 Feb 1997, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

A. D. Kjaergaard, J. S. Johansen, S. E. Bojesen & B. G. Nordestgaard. (2016) Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Critical Reviews in Clinical Laboratory Sciences 53:6, pages 396-408.
Read now
Anne K. Mylin, Niels Abildgaard, Julia S. Johansen, Lene Heickendorff, Svend Kreiner, Anders Waage, Ingemar Turesson & Peter Gimsing. (2015) Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma. Leukemia & Lymphoma 56:9, pages 2650-2659.
Read now
Søren Møller & Flemming Bendtsen. (2015) Complications of cirrhosis. A 50 years flashback. Scandinavian Journal of Gastroenterology 50:6, pages 763-780.
Read now
Leonardo L. Schiavon, Roberto J. Carvalho-Filho, Janaína L. Narciso-Schiavon, José O. Medina-Pestana, Valéria P. Lanzoni, Maria Lucia G. Ferraz & Antonio Eduardo B. Silva. (2010) YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection. Scandinavian Journal of Gastroenterology 45:5, pages 615-622.
Read now
Frederick D. Coffman. (2008) Chitinase 3-Like-1 (CHI3L1): A Putative Disease Marker at the Interface of Proteomics and Glycomics. Critical Reviews in Clinical Laboratory Sciences 45:6, pages 531-562.
Read now
Julia S Johansen, Benny Vittrup Jensen, Anne Roslind & Paul A Price. (2007) Is YKL-40 a new therapeutic target in cancer?. Expert Opinion on Therapeutic Targets 11:2, pages 219-234.
Read now
Luisa Deutsch. (2007) Evaluation of the Effect of Neptune Krill Oil on Chronic Inflammation and Arthritic Symptoms. Journal of the American College of Nutrition 26:1, pages 39-48.
Read now
Birgitte Volck, Keld Østergaard, Julia Johansen, Charly Garbarsch, P.A Price. (1999) The Distribution of YKL-40 in Osteoarthritic and Normal Human Articular Cartilage. Scandinavian Journal of Rheumatology 28:3, pages 171-179.
Read now
H J Møller. (1998) Connective tissue markers of rheumatoid arthritis. Scandinavian Journal of Clinical and Laboratory Investigation 58:4, pages 269-278.
Read now

Articles from other publishers (81)

Minji Kim, Ju Young Chang, Dong won Lee, Yu Ri Kim, Dong Ju Son, Jaesuk Yun, Young Suk Jung, Dong Hun Lee, Sangbae Han & Jin Tae Hong. (2023) Chitinase 3 like 1 deficiency ameliorates lipopolysaccharide-induced acute liver injury by inhibition of M2 macrophage polarization. Molecular Immunology 156, pages 98-110.
Crossref
Kazuaki Okawa, Eri Tabata, Yuta Kida, Kyohei Uno, Hidetoshi Suzuki, Minori Kamaya, Peter O. Bauer & Fumitaka Oyama. (2023) Irreversible evolutionary loss of chitin‐degrading ability in the chitinase‐like protein Y m1 under positive selection in rodents . Protein Science 32:4.
Crossref
Alessandro Bombaci, Umberto Manera, Giovanni De Marco, Federico Casale, Paolina Salamone, Giuseppe Fuda, Giulia Marchese, Barbara Iazzolino, Laura Peotta, Cristina Moglia, Andrea Calvo & Adriano Chiò. (2023) Plasma CHI3L1 in Amyotrophic Lateral Sclerosis: A Potential Differential Diagnostic Biomarker. Journal of Clinical Medicine 12:6, pages 2367.
Crossref
Buğra Kerget, Hatice Beyza Özkan, Dursun Erol Afşin, Abdullah Osman Koçak, Esra Laloglu, Elif Yılmazel Uçar & Leyla Sağlam. (2022) Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism. Clinical Biochemistry 108, pages 20-26.
Crossref
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur & Angeliki M. Angelidi. (2022) Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 12:2, pages 407.
Crossref
Kohsuke Yamada, Toru Hyodo, Syunichiro Urabe, Satomi Haga & Toshio Hosaka. (2022) Serum YKL-40 Level is Associated with Geriatric Nutritional Risk Index (GNRI) and γ-GTP in Hemodialysis Patients. The Journal of Medical Investigation 69:1.2, pages 101-106.
Crossref
Ummugulsum Can. 2022. Biomarkers in Nutrition. Biomarkers in Nutrition 767 785 .
Ummugulsum Can. 2022. Biomarkers in Nutrition. Biomarkers in Nutrition 1 20 .
Memduh Sahin, Pinar Sucu, Erdinc Serin, Aylin Yetim, Huseyin Alkim & Canan Alkim. (2021) Serum fibrosis markers could aid in the prediction of factor for successful oral antiviral treatment in hepatitis C. European Journal of Gastroenterology & Hepatology 33:1S, pages e348-e354.
Crossref
Amit Das, ABM Kamrul-Hasan, MohammedRuhul Kabir, Shantanu Das, KMJ Zaki & Mamun Al Mahtab. (2021) Evaluation of Chitinase 3-like 1 (CHI3L1) as a noninvasive biomarker of hepatic fibrosis in patients with Hepatitis B virus–related compensated chronic liver disease. Journal of Family Medicine and Primary Care 10:4, pages 1694.
Crossref
Jörn Steinke, Stefanie Samietz, Nele Friedrich, Stefan Weiss, Stephan Michalik, Reiner Biffar, Matthias Nauck, Uwe Völker, Henri Wallaschofski, Maik Pietzner & Anke Hannemann. (2020) Associations of plasma YKL-40 concentrations with heel ultrasound parameters and bone turnover markers in the general adult population. Bone 141, pages 115675.
Crossref
Shuwei Wang, Mengyuan Hu, Yunsong Qian, Zhenluo Jiang, Lili Shen, Liyun Fu & Yaoren Hu. (2020) CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomedicine & Pharmacotherapy 131, pages 110680.
Crossref
唤 木. (2020) Research Progress of New Serological Markers of Chronic Hepatitis B Liver Inflammation and Fibrosis. Advances in Clinical Medicine 10:11, pages 2756-2760.
Crossref
In Jun Yeo, Chong-Kil Lee, Sang-Bae Han, Jaesuk Yun & Jin Tae Hong. (2019) Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacology & Therapeutics 203, pages 107394.
Crossref
Fikriye MİLLETLİ SEZGİN & Rukiye NAR. (2019) Determination of serum YKL-40 levels in patients with brucellosisBruselloz hastalarında serum YKL-40 düzeylerinin belirlenmesi. Turkish Journal of Clinics and Laboratory 10:3, pages 335-339.
Crossref
Mette Juul Nielsen, Morten A. Karsdal, Aleksander Krag & Diana Julie Leeming. 2019. The Human Gut-Liver-Axis in Health and Disease. The Human Gut-Liver-Axis in Health and Disease 265 286 .
Linlin Yan, Yongqiong Deng, Jiyuan Zhou, Hong Zhao & Guiqiang Wang. (2018) Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT. Infection 46:3, pages 385-393.
Crossref
Tuija Väänänen, Lauri Lehtimäki, Katriina Vuolteenaho, Mari Hämäläinen, Panu Oksa, Tuula Vierikko, Ritva Järvenpää, Jukka Uitti, Hannu Kankaanranta & Eeva Moilanen. (2017) Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects. Mediators of Inflammation 2017, pages 1-7.
Crossref
Salvatore Musumeci. 2017. Biomarkers in Liver Disease. Biomarkers in Liver Disease 513 526 .
Mette J. Nielsen, Diana J. Leeming, Morten A. Karsdal & Aleksander Krag. 2017. Biomarkers in Liver Disease. Biomarkers in Liver Disease 221 246 .
Daniel Elieh Ali Komi, Tohid Kazemi & Anton Pieter Bussink. (2016) New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma. Current Allergy and Asthma Reports 16:8.
Crossref
Stephanie J. Bissel, Julia Kofler, Julia Nyaundi, Michael Murphey-Corb, Stephen R. Wisniewski & Clayton A. Wiley. (2016) Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis. Journal of Neuroimmune Pharmacology 11:2, pages 332-347.
Crossref
Mohamed Abo El-Asrar, Nancy Samir Elbarbary, Eman Abdel Rahman Ismail & Ahmed Mohamed Elshenity. (2016) Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications. Blood Cells, Molecules, and Diseases 56:1, pages 1-8.
Crossref
Salvatore Musumeci. 2016. Biomarkers in Liver Disease. Biomarkers in Liver Disease 1 14 .
Stefan Bohr, Suraj J. Patel, Radovan Vasko, Keyue Shen, Alexander Golberg, Francois Berthiaume & Martin L. Yarmush. (2015) The Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse Model. PLOS ONE 10:11, pages e0140440.
Crossref
Haijun HuangTiangang WuJian MaoYongxing FangJiajie ZhangLihua WuShu ZhengBiaoyang LinHongying Pan. (2015) CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis. OMICS: A Journal of Integrative Biology 19:6, pages 339-345.
Crossref
Misa Ohno, Peter Bauer, Yuta Kida, Masayoshi Sakaguchi, Yasusato Sugahara & Fumitaka Oyama. (2015) Quantitative Real-Time PCR Analysis of YKL-40 and Its Comparison with Mammalian Chitinase mRNAs in Normal Human Tissues Using a Single Standard DNA. International Journal of Molecular Sciences 16:12, pages 9922-9935.
Crossref
Reetika Bhardwaj, Jessie W. Yester, Sandeep K. Singh, Debolina D. Biswas, Michael J. Surace, Michael R. Waters, Kurt F. Hauser, Zhenqiang Yao, Brendan F. Boyce & Tomasz Kordula. (2015) RelB/p50 Complexes Regulate Cytokine-Induced YKL-40 Expression. The Journal of Immunology 194:6, pages 2862-2870.
Crossref
Elena Paschetta, Paola Belci, Anna Alisi, Daniela Liccardo, Renato Cutrera, Giovanni Musso & Valerio Nobili. (2015) OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease. Mediators of Inflammation 2015, pages 1-10.
Crossref
Camilla Nøjgaard, Julia S. Johansen, Peter Bjerregaard, Stig E. Bojesen & Ulrik Becker. (2015) Plasma YKL-40 in Inuit and Danes. Alcohol and Alcoholism 50:1, pages 11-17.
Crossref
Mette J. Nielsen, Diana J. Leeming, Morten A. Karsdal & Aleksander Krag. 2016. Biomarkers in Liver Disease. Biomarkers in Liver Disease 1 26 .
Misa Ohno, Yuta Kida, Masayoshi Sakaguchi, Yasusato Sugahara & Fumitaka Oyama. (2014) Establishment of a quantitative PCR system for discriminating chitinase-like proteins: catalytically inactive breast regression protein-39 and Ym1 are constitutive genes in mouse lung. BMC Molecular Biology 15:1.
Crossref
Alisa D Kjaergaard, Stig E Bojesen, Børge G Nordestgaard & Julia S Johansen. (2014) YKL-40 and Alcoholic Liver and Pancreas Damage and Disease in 86258 Individuals from the General Population: Cohort and Mendelian Randomization Studies. Clinical Chemistry 60:11, pages 1429-1440.
Crossref
Sebastian Mueller. (2014) Non-invasive diagnosis of alcoholic liver disease. World Journal of Gastroenterology 20:40, pages 14626.
Crossref
Maria Musumeci, Vincenzo Caruso, Emilia Medulla, Venerando Torrisi, Roberta Migale, Silvia Angeletti & Salvatore Musumeci. (2014) Serum YKL-40 Levels and Chitotriosidase Activity in Patients with Beta-Thalassemia Major. Disease Markers 2014, pages 1-6.
Crossref
Stephania Libreros, Ramon Garcia-Areas & Vijaya Iragavarapu-Charyulu. (2013) CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors. Immunologic Research 57:1-3, pages 99-105.
Crossref
Daniel J. Hoover, Viola Zhu, Ru Chen, Ken Briley, Pranela Rameshwar, Stanley Cohen & Frederick D. Coffman. (2013) Expression of the Chitinase Family Glycoprotein YKL-40 in Undifferentiated, Differentiated and Trans-Differentiated Mesenchymal Stem Cells. PLoS ONE 8:5, pages e62491.
Crossref
Gülay Ulusal Okyay, Ramazan Erdem Er, Merve Yasemin Tekbudak, Özge Paşaoğlu, Salih İnal, Kürşad Öneç, Hatice Paşaoğlu, Kadriye Altok, Ülver Derici & Yasemin Erten. (2013) Novel Inflammatory Marker in Dialysis Patients: YKL-40. Therapeutic Apheresis and Dialysis 17:2, pages 193-201.
Crossref
Hao Tang, Yu Sun, Zhaoquan Shi, Hai Huang, Zheng Fang, Jiquan Chen, Qingyu Xiu & Bing Li. (2013) YKL-40 Induces IL-8 Expression from Bronchial Epithelium via MAPK (JNK and ERK) and NF-κB Pathways, Causing Bronchial Smooth Muscle Proliferation and Migration. The Journal of Immunology 190:1, pages 438-446.
Crossref
Sudeep Tanwar, Paul M. Trembling, Indra N. Guha, Julie Parkes, Philip Kaye, Alastair D. Burt, Stephen D. Ryder, Guruprasad P. Aithal, Christopher P. Day & William M. Rosenberg. (2013) Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatology 57:1, pages 103-111.
Crossref
Chun Geun Lee, Charles S. Dela Cruz, Bing Ma, Farida Ahangari, Yang Zhou, Ruth Halaban, Mario Sznol & Jack A. Elias. (2012) Chitinase-like Proteins in Lung Injury, Repair, and Metastasis. Proceedings of the American Thoracic Society 9:2, pages 57-61.
Crossref
G. S. GuptaRajesh K. Gupta & G. S. Gupta. 2012. Animal Lectins: Form, Function and Clinical Applications. Animal Lectins: Form, Function and Clinical Applications 421 437 .
Chun Geun LeeCarla A. Da SilvaCharles S. Dela CruzFarida AhangariBing MaMin-Jong KangChuan-Hua HeSeyedtaghi Takyar & Jack A. Elias. (2011) Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury. Annual Review of Physiology 73:1, pages 479-501.
Crossref
Peter Jarčuška, Martin Janičko, Eduard Veselíny, Pavol Jarčuška & Ľubomír Skladaný. (2010) Circulating markers of liver fibrosis progression. Clinica Chimica Acta 411:15-16, pages 1009-1017.
Crossref
Nicolai A. Schultz & Julia S. Johansen. (2010) YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?. Cancers 2:3, pages 1453-1491.
Crossref
Chun Geun LeeJack A Elias. (2010) Role of breast regression protein-39/YKL-40 in asthma and allergic responses. Allergy, Asthma and Immunology Research 2:1, pages 20.
Crossref
Julia S JohansenNicolai A Schultz & Benny V Jensen. (2009) Plasma YKL-40: a potential new cancer biomarker?. Future Oncology 5:7, pages 1065-1082.
Crossref
T. E. Sutherland, R. M. Maizels & J. E. Allen. (2009) Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clinical & Experimental Allergy 39:7, pages 943-955.
Crossref
Kazuo Yamada, Eiji Hattori, Yoshimi Iwayama, Tomoko Toyota, Tetsuo Ohnishi, Yasuhide Iwata, Kenji J. Tsuchiya, Genichi Sugihara, Mitsuru Kikuchi, Yuji Okazaki & Takeo Yoshikawa. (2008) Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations . American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B:4, pages 508-514.
Crossref
Ashok K. Mohanty, Andrew J. Fisher, Zhihao Yu, Mangottil A. Pradeep, Jagdeesh Janjanam & Jai K. Kaushik. (2009) Cloning, expression, characterization and crystallization of BRP39, a signalling glycoprotein expressed during mammary gland apoptosis. Protein Expression and Purification 64:2, pages 213-218.
Crossref
Dominik Hartl, Chun G Lee, Carla A Da Silva, Geoffrey L Chupp & Jack A Elias. (2009) Novel biomarkers in asthma: chemokines and chitinase-like proteins. Current Opinion in Allergy & Clinical Immunology 9:1, pages 60-66.
Crossref
Katrin Eurich, Mayuko Segawa, Satoko Toei-Shimizu & Emiko Mizoguchi. (2009) Potential role of chitinase 3-like-1 in inflammationassociated carcinogenic changes of epithelial cells. World Journal of Gastroenterology 15:42, pages 5249.
Crossref
Chun Geun Lee. (2009) Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling. Yonsei Medical Journal 50:1, pages 22.
Crossref
L. L. Schiavon, J. L. Narciso-Schiavon, R. J. Carvalho Filho, J. P. Sampaio, J. O. Medina-Pestana, V. P. Lanzoni, A. E. B. Silva & M. L. G. Ferraz. (2008) Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis 15:9, pages 666-674.
Crossref
Yusuf Erzin, Hafize Uzun, Adem Karatas & Aykut Ferhat Celik. (2008) Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease. Journal of Gastroenterology and Hepatology 23:8pt2, pages e357-e362.
Crossref
Preeti Mehta, Robert Ploutz-Snyder, Jyotirmoy Nandi, Sekou R. Rawlins, Schuyler O. Sanderson & Robert A. Levine. (2008) Diagnostic Accuracy of Serum Hyaluronic Acid, FIBROSpect II, and YKL-40 for Discriminating Fibrosis Stages in Chronic Hepatitis C. The American Journal of Gastroenterology 103:4, pages 928-936.
Crossref
Mayumi Kawada, Yuriko Hachiya, Atsuko Arihiro & Emiko Mizoguchi. (2007) Role of mammalian chitinases in inflammatory conditions. The Keio Journal of Medicine 56:1, pages 21-27.
Crossref
Anne K. Mylin, Thomas Rasmussen, Julia S. Johansen, Lene M. Knudsen, Peter H. Nørgaard, Stig Lenhoff, Inger M. S. Dahl & Hans E. Johnsen. (2006) Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells. European Journal of Haematology 77:5, pages 416-424.
Crossref
P. Halfon, M. Bourlière, G. Pénaranda & P. Cacoub. (2006) Les marqueurs sanguins non invasifs de fibrose hépatique au cours de l'infection chronique par le virus de l'hépatite C. La Revue de Médecine Interne 27:10, pages 751-761.
Crossref
Heather F. Bigg, Robin Wait, Andrew D. Rowan & Tim E. Cawston. (2006) The Mammalian Chitinase-like Lectin, YKL-40, Binds Specifically to Type I Collagen and Modulates the Rate of Type I Collagen Fibril Formation. Journal of Biological Chemistry 281:30, pages 21082-21095.
Crossref
Sanaa M. Kamal, Bradley Turner, Qi He, Jens Rasenack, Leonardo Bianchi, Ahmed Al Tawil, Ahmed Nooman, Mahmoud Massoud, Margaret James Koziel & Nezam H. Afdhal. (2006) Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis. Hepatology 43:4, pages 771-779.
Crossref
Anneliese D. Recklies, Hua Ling, Chantal White & Suzanne M. Bernier. (2005) Inflammatory Cytokines Induce Production of CHI3L1 by Articular Chondrocytes. Journal of Biological Chemistry 280:50, pages 41213-41221.
Crossref
Min Zheng, Cai Wei-Min, Zhao Jun-Kang, Zhu Shao-Ming & Liu Rong-Hua. (2005) Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value. Acta Tropica 96:2-3, pages 148-152.
Crossref
Yukiko Saitou. (2005) Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World Journal of Gastroenterology 11:4, pages 476.
Crossref
Nezam H. Afdhal & David Nunes. (2004) Evaluation of Liver Fibrosis: A Concise Review. The American Journal of Gastroenterology 99:6, pages 1160-1174.
Crossref
Michael Rehli, Hans-Helmut Niller, Christoph Ammon, Sabine Langmann, Lucia Schwarzfischer, Reinhard Andreesen & Stefan W. Krause. (2003) Transcriptional Regulation of CHI3L1, a Marker Gene for Late Stages of Macrophage Differentiation. Journal of Biological Chemistry 278:45, pages 44058-44067.
Crossref
Daniela Bernardi, Marta Podswiadek, Martina Zaninotto, Leonardo Punzi & Mario Plebani. (2003) YKL-40 as a Marker of Joint Involvement in Inflammatory Bowel Disease. Clinical Chemistry 49:10, pages 1685-1688.
Crossref
Douglas R. Houston, Anneliese D. Recklies, Joanne C. Krupa & Daan M.F. van Aalten. (2003) Structure and Ligand-induced Conformational Change of the 39-kDa Glycoprotein from Human Articular Chondrocytes. Journal of Biological Chemistry 278:32, pages 30206-30212.
Crossref
Camilla Nøjgaard, Julia S Johansen, Erik Christensen, Lene Theil Skovgaard, Paul A Price & Ulrik Becker. (2003) Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. Journal of Hepatology 39:2, pages 179-186.
Crossref
Helene Sjögren, Jeanne M. Meis-Kindblom, Charlotte Örndal, Peter Bergh, Konrad Ptaszynski, Pierre Åman, Lars-Gunnar Kindblom & Göran Stenman. (2003) Studies on the Molecular Pathogenesis of Extraskeletal Myxoid Chondrosarcoma—Cytogenetic, Molecular Genetic, and cDNA Microarray Analyses. The American Journal of Pathology 162:3, pages 781-792.
Crossref
Eric Steck, Stephen Breit, Steffen J Breusch, Matthias Axt & Wiltrud Richter. (2002) Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage. Biochemical and Biophysical Research Communications 299:1, pages 109-115.
Crossref
Christian Østergaard, Julia S. Johansen, Thomas Benfield, Paul A. Price & Jens D. Lundgren. (2002) YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent Meningitis. Clinical and Vaccine Immunology 9:3, pages 598-604.
Crossref
Sangik Oh & Nezam H. Afdhal. (2001) Hepatic fibrosis: Are any of the serum markers useful?. Current Gastroenterology Reports 3:1, pages 12-18.
Crossref
A. Cenarro, P. Giraldo, J.I. Pérez Calvo & M. Pocoví. (2001) El gen de la â-glucocerebrosidasa: un gen implicado en la enfermedad de Gaucher y en la hipoalfalipoproteinemia. Clínica e Investigación en Arteriosclerosis 13:1, pages 28-35.
Crossref
Julia S Johansen, Per Christoffersen, Søren Møller, Paul A Price, Jens H Henriksen, Charly Garbarsch & Flemming Bendtsen. (2000) Serum YKL-40 is increased in patients with hepatic fibrosis. Journal of Hepatology 32:6, pages 911-920.
Crossref
Carmelo E Fiore, Pietra Pennisi & Corrado Tamborino. (2000) YKL-40 and graft rejection. The American Journal of Medicine 108:8, pages 688-689.
Crossref
J.R. Connor, R.A. Dodds, J.G. Emery, R.B. Kirkpatrick, M. Rosenberg & M. Gowen. (2000) Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization. Osteoarthritis and Cartilage 8:2, pages 87-95.
Crossref
M Silva, B Cauliez, X Le Loet, O goria, E Lerebours & A Lavoinne. (2000) Le chondrex, marqueur du cartilage articulaire et de la fibröse hépatique. Immuno-analyse & Biologie Spécialisée 15:2, pages 114-117.
Crossref
B. Zerahn, A. Kofoed-Enevoldsen, B.V. Jensen, J. Mølvig, N. Ebbehøj, J.S. Johansen & I.-L. Kanstrup. (1999) Pulmonary damage after modest exposure to zinc chloride smoke. Respiratory Medicine 93:12, pages 885-890.
Crossref
Julia S. Johansen, Bo Baslund, Charly Garbarsch, Michael Hansen, Michael Stoltenberg, Ib Lorenzen & Paul A. Price. (1999) YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis & Rheumatism 42:12, pages 2624-2630.
Crossref
Stefan Bl��, Joachim-Michael Engel & Gerd-R�diger Burmester. (1999) The immunologic homunculus in rheumatoid arthritis. Arthritis & Rheumatism 42:12, pages 2499-2506.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.